DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20173283

A cross-sectional study of drug prescription pattern in psoriasis patients attending dermatology and venereology department in a rural tertiary care teaching hospital

Sushil Kumar Varma, Shanta Das Sutradhar

Abstract


Background: Psoriasis is a chronic, inflammatory, multisystem disease which predominantly affects skin, joint, scalp and nail. Treatment strategies for psoriasis include topical therapy, systemic therapy and phototherapy (PT). Treatment usually depends on the severity, location and extent of lesion. Drug prescription studies are necessary for the recognition of areas for improvement and improving drug prescribing practices in hospitals. There are very few reports regarding drug prescription pattern in psoriasis patients. Hence we conducted this study.

Methods: This was a cross-sectional study conducted on 50 newly diagnosed psoriasis patients who attended Dermatology and Venereology outpatient department of a tertiary care hospital. The prescriptions from the patients were collected for the duration of 18 months and details of prescription were collected in case record forms. The assessment of disease severity was done by psoriasis area severity index (PASI) score.

Results: Majority of the patients (46%) belonged to the age group of 41-55years. The mean age of the patients was 42.48±12.29 years. Most of the patients with mild form of psoriasis were treated with topical therapy. Topical therapy included high potency steroids alone or in combination with salicylic acid and calcipotriol. Patients with more severe form of disease received combination of topical, systemic and phototherapy. Systemic therapy included oral Methotrexate and phototherapy was given as narrow band UVB (NBUVB). Further long term study is required to for proper assessment of prescription pattern in psoriasis patients.

Conclusions: Most of the patients with psoriasis can be effectively treated with topical medications, and additional systemic and/or phototherapy may be required only for severe cases.


Keywords


Psoriasis, Phototherapy, PASI score, Systemic therapy, Topical therapy

Full Text:

PDF

References


Shalini S, Ravichandran V, Mohanty BK, Dhanaraj SK, Saraswathi R. Drug utilization studies: an overview. Inter J Pharmaceut Sci Nanotechnol. 2010;3(1):803-10.

Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, South Ethiopia: a cross-sectional study. BMC Health Services Research. 2013;13:170.

Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595-601.

Vijayan M, Shini VK, Emmanuel J, Dharmaratnam AD. Prevalence, clinical profile and prescribing pattern of psoriasis in a tertiary care referral hospital. International Journal of Pharmacy and Technology. 2010 December;2(4):1241-52.

Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB Jr, Feldman SR. Class 1 topical corticosteroid use by psoriasis patients in an academic practice. J Dermatolog Treat. 2004 July;15(4):235-8.

Raghunandan R, Pundarikaksha HP, Gopal MG. Pattern of drug use in the management of psoriasis in a tertiary care hospital: a prospective study. Int J Basic Clin Pharmacol. 2014;3(4):611-8.

Feldman SR, Krueger GG. Assessment: domains and instruments. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(2).

Louden BA, Pearce DJ, Lang W, Feldman SR. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinic patients. Dermatology Online Journal. 2004;10(2):7.

Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Kremers HM. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. Journal of the American Academy of Dermatology. 2009 Mar 31;60(3):394-401.

Haider S, Wahid Z, Najam-us-Saher, Riaz F. Efficacy of Methotrexate in patients with plaque type psoriasis. Pak J Med Sci. 2014;30(5):1050-3.

Ejaz A, Raza N, Iftikhar N, Iftikhar A, Farooq M. Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan. Indian J Dermatol Venereol Leprol. 2009;75:36-40.

Tollefson MM, Crowson CS, Kremers HM. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010 Jun; 62(6):979-87.

Chiriac A, Solovan C, Chiriac AE, Foia L, Brzezinski P. A case-control study of epidemiological importance risk of family history of psoriasis. Our Dermatol Online. 2014;5(1):90-1.

Traub M, Marshall K. Psoriasis-pathophysiology, conventional and alternative approaches to treatment. Altern Med Rev. 2007 Dec;12(4):319-30.

Peters BP, Weissman FG, Mark. Gill. Pathophysiology and treatment of psoriasis. Am J Health-Syst Pharm. April 2000;57.

Mehta S, Singal A, Singh N, Bhattacharya SN. A study of clinicohistopathological correlation in patients of psoriasis and psoriasiform dermatitis. Indian J Dermatol Venereol Leprol. 2009;75:100.

Gillard SE, Finlay AY. Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int. Nov 2005;59(11):1260-7.

NICE clinical guideline 153.Psoriasis: The assessment and management of psoriasis. October 2012. Available at: http://www.nice.org.uk/ guidance/cg153/resources/guidance-psoriasis-pdf

Kozub P, Simaljakova M. Systemic therapy of psoriasis: Methotrexate; Bratisl Lek Listy. 2011;112(7):390-4.

Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, et al. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology. 2009 Nov 1;161(5):987-1019.

Van de Kerkhof PC. Therapeutic strategies: rotational therapy and combinations. van de Kerkhof PC. Clin Exp Dermatol. 2001 Jun;26(4):356-61.